Prescribing information


UKI NETS 2021 symposium


Click below to view this must-watch on-demand video in which the expert panel, Dr Mairéad McNamara, Dr Alia Munir, Dr Francis Sundram and Dr Sebastian Cummins, discuss key strategies for the management of patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) using peptide receptor radionuclide therapy (PRRT).

The latest survival and safety data from the phase III NETTER-1 trial are presented and the benefits of PRRT in this patient population are described using case summaries. The panel, chaired by Dr Mairéad McNamara, also answers critical questions from the audience regarding the use of PRRT in clinical practice.


If you don’t have time to watch the whole video, click on the bookmark button to select a section that interests you.




Please note this is a recording of a virtual symposium and Q&A session sponsored by Novartis, at the December 2021 UKI NETS meeting.


Dr Mairéad McNamara

Senior Lecturer, University of Manchester

Honorary Consultant in Medical Oncology, The Christie NHS Foundation Trust, Manchester

Dr Alia Munir

Consultant Endocrinologist, Sheffield Teaching Hospitals NHS Foundation Trust

Dr Francis Sundram

Consultant in Nuclear Medicine, University Hospital Southampton NHS Foundation Trust

Dr Sebastian Cummins,

Consultant Clinical Oncology, Royal Surrey County Hospital NHS Foundation Trust

AAA-Lu177-UK-2465 | April 2024

Ask Speakers


Medical Information Request